The Future of Computing is Here and Alive: Join the FinalSpark Revolution
In the dynamic world of technology and science, few stories are as inspiring as that of Dr. Fred Jordan, a visionary who has effortlessly merged the realms of deep tech, neurobiology, and entrepreneurship. His journey, from a curious childhood tinkerer to the CEO of FinalSpark, a Swiss startup leading the biocomputing revolution, is a testament to the power of curiosity, innovation, and the relentless pursuit of knowledge.
Nurtured in a family deeply rooted in engineering, Dr. Jordan's fascination with technology began at a young age. This environment of high technical complexity ignited a spark in him, and he soon found himself immersed in the world of coding and robotics. By the age of 16, he was already building robotic arms and complex machines from scratch, driven by a desire to create a "thinking machine."
This early passion led him to explore the theoretical properties of neural networks, positioning him at the forefront of the artificial intelligence field. However, Dr. Jordan wasn't satisfied with merely understanding the brain's potential; he wanted to harness it. This ambition led to the creation of FinalSpark in 2014, alongside his long-time cofounfer, Dr. Martin Cutter.
FinalSpark is not just another tech company. It is a bold experiment in biocomputing, leveraging the unique properties of neurons to develop advanced computational systems. The company's approach is unique: they cultivate human-derived neuro-organoids, miniature 3D structures that mimic the human brain, and connect them to in silico systems. This allows them to study the brain's biological processes and develop AI systems that are more relevant to human cognition.
The potential of this groundbreaking platform is enormous. Biocomputers could be a million times more energy-efficient than traditional AI systems, reducing our environmental impact and unlocking new possibilities in fields like healthcare, robotics, and more. FinalSpark's system is already being used by nine universities around the world for cutting-edge research in biocomputing.
However, the journey to achieve this vision is fraught with challenges. Growing and maintaining large networks of living neurons is a complex process. FinalSpark is tackling these challenges head-on, constantly pushing the boundaries of biocomputing.
The team behind FinalSpark is as impressive as its vision. Dr. Jordan and Dr. Martin Cutter are joined by a diverse group of experts, including biologists, engineers, and advisors with decades of experience. This multidisciplinary approach ensures that FinalSpark is not just a tech company but a hub of innovation where different fields converge to create something extraordinary.
This is your opportunity to be part of a revolution in technology that could redefine the future of computing.
Deep tech investors, FinalSpark is ready to accelerate their research and development. This is an opportunity to invest in a groundbreaking technology that has the potential to revolutionize the world.
Neurobiologists, FinalSpark's work with hippocampal organoids and long-term potentiation is at the forefront of understanding memory and cognition. By collaborating with FinalSpark, you have the chance to contribute to pioneering research that bridges the gap between biology and technology.
Technologists, the FinalSpark platform is a playground for innovation. With its open access, it offers endless possibilities for experimentation and development. Whether you are working on advanced algorithms, object detection, or new computational models, FinalSpark provides the tools and the environment to bring your ideas to life.
The FinalSpark adventure is just beginning. It's a journey that will require vision, collaboration, and a willingness to push the boundaries of what's possible. Are you ready to join?
Contact FinalSpark today and be part of the revolution creating a future where machines think, learn, and perhaps even feel.
Dr. Fred Jordan and Dr Martin Cutter are the co-founders of AlpVision.
Dr Jordan has served as CEO since June 2001. He is the author of numerous scientific publications, patents, and co-inventor of Cryptoglyph and Fingerprint, AlpVision’s core technologies. Dr. Jordan has extensive experience working in the United States and in France. In 1999, he received his PhD from the Swiss Technology Institute (EPFL) – Signal Processing Institute (ITS) in Lausanne.
Co-host of this episode:
Dr. Benjamin Delsol, Quantum Physicist, Deep Tech Expert and European Patent Attorney
ITW + IP Masterclass of Benjamin 👉https://www.episteme-entrepreneur.com/blog/benjamin-delsol-physique-quantique-propriete-intellectuelle-brevet-deep-tech